{"id":"W2142506642","doi":"10.1200/jco.2012.44.4489","title":"Effect of Ruxolitinib Therapy on Myelofibrosis-Related Symptoms and Other Patient-Reported Outcomes in COMFORT-I: A Randomized, Double-Blind, Placebo-Controlled Trial","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Incyte; American Society of Clinical Oncology; Sanofi","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Placebo; Quality of life (healthcare); Internal medicine; Physical therapy; Clinical trial; Randomized controlled trial; Bone marrow; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001564482,0.001574812,0.003744842,0.0004726248,0.0004908125,0.001015465,0.0008669048,0.002927095,0.005552122],"category_scores_gemma":[0.001693168,0.0005484481,0.002451885,0.0004166859,0.0009864983,0.0008870512,0.0003740565,0.00203459,0.0006869789],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004571654,"about_ca_system_score_gemma":0.000757263,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004341195,"about_ca_topic_score_gemma":0.000981507,"domain_scores_codex":[0.9991903,0.0004163987,0.00007639504,0.0001384499,0.00006413597,0.0001144789],"domain_scores_gemma":[0.9991204,0.0002325221,0.0002942886,0.00006680631,0.00006241813,0.0002235275],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9804802,0.004028559,0.0004477,0.001086524,0.0009580715,0.00003166708,0.00002129686,0.0001282363,0.001662834,0.00005955618,0.0003669264,0.01072832],"study_design_scores_gemma":[0.9615028,0.03597612,0.001331705,0.00004067944,0.0004158311,0.00002318663,0.000008742853,0.0001775921,0.0002370966,0.0000423017,0.0002340132,0.000009967318],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9750205,0.01482248,0.0006602973,0.0006712861,0.0005875708,0.004362266,0.001135651,0.0001976195,0.002542462],"genre_scores_gemma":[0.9857188,0.003280659,0.001105863,0.001029999,0.0006837409,0.005829894,0.0009468581,0.00001435237,0.001389718],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005552122,"threshold_uncertainty_score":0.01857364,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.063216412113048,"score_gpt":0.4266609432678403,"score_spread":0.3634445311547923,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}